Skip to search formSkip to main contentSkip to account menu

N-acetylglucopyranosylamine

Known as: 1-GlcNAc, N-acetyl-beta-D-glucopyranosylamine 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Glucosamine
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Two distinct glycogen phosphorylase inhibitors, 5-chloro-1H-indole-2-carboxylic acid [1-(4-fluorobenzyl)-2-(4-hydroxy-piperidin-1… 
1997
1997
N-Acetyl-beta-D-glucopyranosylamine 6-phosphate is a specific inhibitor of glycogen-bound protein phosphatase 1.
  • M. Board
  • Biochemical Journal
  • 1997
  • Corpus ID: 24627437
Previous work has shown that the C-1-substituted glucose-analogue N-acetyl-beta-D-glucopyranosylamine (1-GlcNAc) is a competitive… 
1997
1997
N-Acetyl-β-D-glucopyranosylamine 6-phosphate is a specific inhibitor of glycogen-bound protein phosphatase 1
Previous work has shown that the C-1-substituted glucoseanalogue N-acetyl-β--glucopyranosylamine (1-GlcNAc) is a competitive… 
Highly Cited
1995
Highly Cited
1995
N‐acetyl‐β‐D‐glucopyranosylamine: A potent T‐state inhibitor of glycogen phosphorylase. A comparison with α‐D‐glucose
Structure‐based drug design has led to the discovery of a number of glucose analogue inhibitors of glycogen phosphorylase that… 
1995
1995
Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes.
A series of glucose-analogue inhibitors of glycogen phosphorylase b (GPb) has been designed, synthesized and investigated in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)